Fredun Pharmaceuticals Ltd (FREDUN) Financials - Quarterly Results, Profit & Loss, Balance Sheet, Cash Flow Fredun Pharmaceuticals Ltd reported sales of ₹228 Cr, operating profit of ₹33 Cr (OPM 14%) and net profit of ₹13 Cr for the quarter ended Jun 2026. Figures in ₹ crore, consolidated where available.
FREDUN quarterly results (₹ Cr) Metric Sep 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sales 0 167 120 145 161 213 228 Expenses 0 150 103 123 135 184 196 Operating Profit 0 17 17 22 26 29 33 OPM - 10% 14% 15% 16% 14% 14% Other Income 0 0 0 0 0 0 0 Interest 0 8 7 8 11 14 9 Depreciation 0 2 1 2 2 3 4 Profit before tax 0 7 9 13 14 11 21 Tax - 17% 25% 26% 25% 4% 36% Net Profit 0 6 7 9 10 11 13 EPS in Rs 0 4.23 4.77 6.64 6.51 6.57 7.96
FREDUN profit & loss, annual (₹ Cr) Metric Mar 2025 Mar 2026 TTM Sales 454 635 748 Expenses 401 545 637 Operating Profit 52 91 110 OPM 12% 14% 15% Other Income 2 4 0 Interest 22 39 41 Depreciation 5 8 10 Profit before tax 27 47 59 Tax 28% 31% - Net Profit 20 33 44 EPS in Rs 13.9 19.89 27.68 Dividend Payout 2% 1% -
FREDUN balance sheet (₹ Cr) Metric Mar 2025 Sep 2025 Mar 2026 Equity Capital 5 5 5 Reserves 137 153 273 Borrowings 167 171 222 Other Liabilities 179 136 142 Total Liabilities 487 464 642 Fixed Assets 53 66 118 CWIP 0 0 0 Investments 2 2 2 Other Assets 433 397 522 Total Assets 487 464 642
FREDUN cash flows (₹ Cr) Metric Mar 2025 Mar 2026 Cash from Operating Activity -17 12 Cash from Investing Activity -6 -74 Cash from Financing Activity 27 121 Net Cash Flow 4 60 Free Cash Flow -23 -62 CFO/OP -32% 13%
FREDUN ratios Metric Mar 2025 Mar 2026 Debtor Days 142 53 Inventory Days 267 219 Days Payable 161 71 Cash Conversion Cycle 248 201 Working Capital Days 76 78 ROCE - 21%